MD Stock 12 Month Analyst Forecast
Eps Overview
Consensus Rating
Consensus Price Target
Highest Price Target
$24.00
7.1% Upside
Mean Price Target
$21.50
-4.06% Downside
Lowest Price Target
$16.50
-26.37% Downside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On Apr 14, 2026
Actual EPS vs Estimated EPS
MD Earnings Per Share (EPS) History
According to financial reports, MD (NYSE: MD) reported an actual EPS of $0.5 for the quarter ending on Feb 19, 2026, compared to an estimated $0.53, resulting in a -5.66% surprise. In the prior quarter (Nov 03, 2025), MD recorded an actual EPS of $0.838 with a 82.17% surprise. See MD's full earnings history.
Earnings History
EPS Surprise Factor Analysis
MD has experienced notable EPS surprises, with the latest quarter ending Feb 19, 2026 showing a -5.66% miss. Previously, the quarter ending Nov 03, 2025 recorded a 82.17% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Feb 19, 2026 | 0.5 | 0.53 | -5.66% |
| Nov 03, 2025 | 0.838 | 0.46 | +82.17% |
| Aug 05, 2025 | 0.53 | 0.42 | +26.19% |
| May 06, 2025 | 0.33 | 0.25 | +32.00% |
| Feb 20, 2025 | 0.51 | 0.37 | +37.84% |
| Nov 01, 2024 | 0.23 | 0.37 | -37.84% |

